Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Provexis ( (GB:PXS) ) has provided an announcement.
Provexis has announced its total voting rights as 2,345,891,239 ordinary shares. The company’s collaboration with BYHEALTH has progressed, with major developments for Fruitflow in China, including the submission of new health function claims, reflecting the significant investment and research efforts. This expansion and regulatory advancement in China are poised to impact Provexis’ market positioning positively.
More about Provexis
Provexis plc is a company in the health food industry, focusing on the development, licensing, and sales of its proprietary, scientifically-proven Fruitflow® ingredient. The company offers a heart-health functional food ingredient that promotes cardiovascular health by aiding normal blood flow and circulation. Provexis works closely with BYHEALTH for the development of Fruitflow-based products in the Chinese market.
YTD Price Performance: 3.85%
Average Trading Volume: 503,825
Technical Sentiment Consensus Rating: Sell
Current Market Cap: £15.83M
See more data about PXS stock on TipRanks’ Stock Analysis page.
